Form 8-K - Current report:
SEC Accession No. 0001558370-25-010176
Filing Date
2025-08-05
Accepted
2025-08-05 07:05:14
Documents
13
Period of Report
2025-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rytm-20250805x8k.htm   iXBRL 8-K 31592
2 EX-99.1 rytm-20250805xex99d1.htm EX-99.1 303922
  Complete submission text file 0001558370-25-010176.txt   470958

Data Files

Seq Description Document Type Size
3 EX-101.SCH rytm-20250805.xsd EX-101.SCH 3457
4 EX-101.LAB rytm-20250805_lab.xml EX-101.LAB 15924
5 EX-101.PRE rytm-20250805_pre.xml EX-101.PRE 10322
15 EXTRACTED XBRL INSTANCE DOCUMENT rytm-20250805x8k_htm.xml XML 4809
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38223 | Film No.: 251182752
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)